Cell and gene therapies (CGT) continue to advance in the pharmaceutical industry. Despite continued investment in R&D, the ...

Now, a global clinical trial has shown promising results in extending survival for patients with TNBC. The TROPION-Breast02 ...

Paterna Biosciences says it has determined the set of instructions needed to turn sperm-making stem cells into "normal, ...

Franklin Equity reported on February 16 that, following a protracted period of uncertainty in the previous year, the ...

The Emirates Drug Establishment (EDE) has announced the country’s first fully AI-discovered and developed drug candidate by a ...

A cancer patient and her research nurse are joining forces to run the London Marathon this weekend ...

Most of the lawsuits initially filed in response to Operation Metro Surge are still in the process of gathering and ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast in which we bring you the latest insights shaping patient access, ...